[Previous Months][Date Index][Thread Index][Join - Register][Login]
[Message Prev][Message Next][Thread Prev][Thread Next]

[IP] Minimed Inc. Comments On HCFA Decision to Expand Coverage for Insulin Pumps


Minimed Inc. Comments On HCFA Decision to Expand Coverage for Insulin Pumps


NORTHRIDGE, Calif., June 6  MiniMed Inc. (Nasdaq:MNMD) commented today on 
the announcement made by the Health Care Finance Administration that 
Medicare will expand its coverage of insulin infusion pumps and related 
supplies for eligible beneficiaries with diabetes
      The recent HCFA decision provides greater coverage for people with 
diabetes and enables some patients with Type 2 diabetes, who had previously 
been excluded from coverage, to qualify for reimbursement. HCFA has been 
providing reimbursement for qualified Type 1 patients for approximately one 
year. HCFA coverage approval is based upon a particular laboratory 
diagnostic test of C-peptide levels, which reflects the ability of the 
pancreas to produce insulin.
       Commenting on the news, Alfred E. Mann, MiniMed's Executive Chairman, 
said, "We are very pleased with HCFA's action to expand the coverage 
criteria for insulin infusion pump therapy for eligible Medicare patients 
with diabetes. This decision will enable more diabetes patients, including 
some Type 2 diabetics, to benefit from insulin pump therapy. The long term 
consequences of diabetes are devastating if the disease is not effectively 
managed, with tremendous costs in terms of both human suffering and expense 
to the health care system. We commend HCFA's Coverage and Analysis Group for 
their proactive monitoring of this therapy coverage."
       Terrance H. Gregg, President and Chief Operating Officer, added, "The 
decision by HCFA to revise its coverage criteria is further evidence of the 
growing acceptance and importance of insulin pump therapy in the health care 
community. As more diabetes patients and their care givers select insulin 
pumps as the best way to manage the disease, this decision will make it 
easier for Medicare patients to benefit from this therapy. By making this 
adjustment after just one year of initial coverage, HCFA has demonstrated 
its commitment to providing the best care possible for its beneficiaries who 
must live with diabetes. The decision establishes a precedent for qualified 
Type 2 diabetes patients to benefit from insulin pump therapy."

Get your FREE download of MSN Explorer at http://explorer.msn.com
for HELP or to subscribe/unsubscribe, contact: HELP@insulin-pumpers.org
send a DONATION http://www.Insulin-Pumpers.org/donate.shtml